Guilin Sanjin said in an online briefing that Sanjin Granules, a key product the company is prioritizing, has seen rapid sales growth but its revenue base remains small and its contribution to total volumes is not yet material; achieving scale will take time. The company will accelerate hospital-channel sales to try to bring the product to scale sooner.

2026-11-09

Guilin Sanjin said in an online briefing that Sanjin Granules, a key product the company is prioritizing, has seen rapid sales growth but its revenue base remains small and its contribution to total volumes is not yet material; achieving scale will take time. The company will accelerate hospital-channel sales to try to bring the product to scale sooner.